Dodel, R., Rominger, A., Bartenstein, P., Barkhof, F., Blennow, K., Förster, S., . . . Jessen, F. (2013). Intravenous immunoglobulins for the treatment of mild to moderate Alzheimer’s disease: A phase II, randomised, double-blind, placebo-controlled dose-finding trial. Lancet Neurol.
Citação norma ChicagoDodel, Richard, et al. "Intravenous Immunoglobulins for the Treatment of Mild to Moderate Alzheimer’s Disease: A Phase II, Randomised, Double-blind, Placebo-controlled Dose-finding Trial." Lancet Neurol 2013.
Citação norma MLADodel, Richard, et al. "Intravenous Immunoglobulins for the Treatment of Mild to Moderate Alzheimer’s Disease: A Phase II, Randomised, Double-blind, Placebo-controlled Dose-finding Trial." Lancet Neurol 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.